If you guessed C, you’re right! 🙌 Upstaged NSCLC needs adjuvant chemo, then immunotherapy for PD-L1 1% or higher.

Subscribe to ASCO-SEP® today: bit.ly/4zrBqwc

ASCO members get 20% off; additional discounts available.

How has teamwork transformed patient outcomes in your practice? Bring Dr. Elizabeth Mittendorf’s Presidential theme—Intentional Teams. Exceptional Care.—to life on the #ASCO27 stage during the ASCO Voices session.

🎙️ Submit your audition by November 13: https://bit.ly/4ysuMWe

Test your clinical knowledge with a ❓ from our ASCO-SEP Question Bank!

Q: Pt (67) s/p resection for 1.5-cm lung adenocarcinoma, positive nodes. Next step?

1️⃣ Close surveillance
2️⃣ Adj chemo-RT
3️⃣ Adj chemo, then immunotherapy
4️⃣ Adj immunotherapy

📊 Show results

Don’t miss your opportunity to contribute to the evolution of patient-centered care by submitting your research to #GU27! Bring your latest innovations in GU cancer research and connect with global leaders.

Abstracts are due Oct 13 at 11:59 PM (ET): https://bit.ly/3T3X5uX
@astro-org.bsky.social

In September, an FDA advisory committee voted in support of the Galleri multicancer early detection test, the first to reach this stage. Now oncologists need to prepare for the patient questions to follow. Dr. Michael LaPelusa has more for #ASCODailyNews: https://bit.ly/4xScPPJ

Attention oncology professionals in Africa – Apply for the ASCO and AORTIC ICRS program and gain 1-year of hybrid training + mentorship to enhance investigation skills & improve care within your community. Deadline: Dec. 1, 2026.

Apply now: https://bit.ly/4xVcT1k
#ASCOGlobalImpact

Deadline approaching! Applications for the mentored Career Development Award (CDA) close Oct. 8 at 11:59 PM ET. Secure funding from @conquercancer.bsky.social to establish your independent clinical research program.

Apply today: https://bit.ly/46Mbf71
#ResearchConquersCancer

Our draft guideline protocol for “Treatment of Metastatic Colorectal Cancer: ASCO Guideline Update” is now open for public comment. Help us determine the scope of the guideline. Submit your comments to us by October 16.

Read and comment here: https://bit.ly/4rElmED

Drs. Sumanta Pal of @cityofhope.bsky.social, Marc Braunstein of Perlmutter Cancer Center, and Rahul Banerjee of Fred Hutch Cancer Center discuss CAR T cells, bispecific antibodies and the new era of multiple myeloma care on the latest episode of the #ASCODailyNews Podcast: https://bit.ly/46OHFxR

We are honoring Dr. Areej R. El-Jawahri w/the 2026 Joseph Simone Quality Care Award at the upcoming #ASCOQLTY26!

Read about her journey & finding purpose in every aspect of cancer care: https://bit.ly/4ypiCh1

Updated ASCO Guideline for first-line HER2 + gastroesophageal carcinoma:
💠 PD-L1 ≥1 (pMMR/MSS): HER2 antibody + immunotherapy + fluoropyrimidine & platinum chemo
💠PD-L1 <1 (pMMR/MSS): HER2 antibody + fluoropyrimidine & platinum chemo
Read the updated guideline: https://bit.ly/4AzBNWH
#ASCOGuidelines

Ready to build a sustainable network of palliative care professionals? Partner with ASCO for a multi-year education collaboration featuring a Train the Trainer model, virtual training, & an advanced in-person clinical course.

🗓️ Proposals due November 30: https://bit.ly/4AyHGDs
#ASCOGlobalImpact

ASCO Guideline Update: Therapy for Stage IV NSCLC w/ Driver Alterations

For first-line EGFR exon 20 insertions, clinicians should offer sunvozertinib monotherapy or platinum doublet chemotherapy plus amivantamab.

Read the updated guideline: https://bit.ly/46JViOM
#ASCOGuidelines

Short on time? See if you can vote by mail for the U.S. General election and vote on your schedule! Visit: nass.org/can-I-vote to prepare your voting plan today. Don’t wait! #ASCOAdvocacy

ASCO & @who.int have signed a collaboration agreement to address international challenges in accessing quality cancer care. Key focus areas: professional capacity building, clinical trial access, & quality & accountability. Read the announcement : https://bit.ly/4hiGpJs

Announcing the ASCO Quality Care Symposium Featured Voices! Follow them before, during, and after the meeting for expert insights. Join the conversation w/ the official hashtag #ASCOQLTY26.

Registration is open: https://bit.ly/4hOQAEH

FDA approval of post-surgery #pembro + belzutifan adds a treatment option for patients with higher-risk #ccRCC. But does it change practice? Read more from Dr. Stepan M. Esagian, Dr. Pavlos Msaouel, and Dr. Andrew W. Hahn for #ASCODailyNews: https://bit.ly/4ABHaF2

UPDATE! All gifts now doubled for World Cancer Research Day thanks to a generous matching gift! This #WorldCancerResearchDay, help provide resources needed to make more possible for people everywhere waiting for breakthroughs. Make a gift today https://bit.ly/3T5kL22 @ascocancer.bsky.social

On this #WorldCancerResearchDay, apply for the @conquercancer.bsky.social Career Development Award (CDA) to secure mentored clinical oncology funding.

Open to US & international initial faculty. Apply by Oct 8: https://bit.ly/4iK0tWc
#ResearchConquersCancer

Today is the 10th anniv. of #WorldCancerResearchDay. Advancing cancer research requires all of us. We drive global innovation through education, mentorship, and funding vital research via @conquercancer.bsky.social Grants & Awards.

Learn more: https://bit.ly/47gdm33
#ResearchConquersCancer